Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules01:45

Positive Regulator Molecules

136.9K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
The Cell Cycle Control System01:28

The Cell Cycle Control System

6.2K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
6.2K
The Cell Cycle Control System02:11

The Cell Cycle Control System

14.7K
The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
14.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The structural basis of RanGAP1 regulation and catalysis in nuclear transport.

bioRxiv : the preprint server for biology·2026
Same author

Direct Mapping of CDK2 Substrates in Embryonic Stem Cells Uncovers an AP-Site Repair Mechanism via HMCES Phosphorylation.

bioRxiv : the preprint server for biology·2026
Same author

ERK autoinhibition mechanism informs a drug combination strategy.

Protein science : a publication of the Protein Society·2026
Same author

A Study of 3-Substituted 7-Methoxy-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>d</i>]azepin-1-ols Leading to Candidate PET Radioligands for Imaging Brain GluN2B: Design, Synthesis, and Structure-Activity Relationships.

Molecules (Basel, Switzerland)·2026
Same author

How Functional Variants Reconfigure the Rac2 Conformational Landscape.

bioRxiv : the preprint server for biology·2026
Same author

Energy landscapes in molecular biology: History, principles, and perspectives.

Quarterly reviews of biophysics·2026

Related Experiment Video

Updated: Mar 11, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K

Cyclin-E/A/CDK1/2 Kinetic Landscapes Drive Cell Cycle Phase-Specific Progression and Guide Cyclin-E Degradation

Wengang Zhang1, Devin Bradburn2, Yonglan Liu1

  • 1Cancer Innovation Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.

Journal of Chemical Information and Modeling
|March 9, 2026
PubMed
Summary

Cell cycle regulation involves cyclin-dependent kinases (CDKs) with phase-specific conformations. This study reveals how CDK complexes like Cyclin-E/CDK2 and Cyclin-A/CDK2 achieve distinct functions, informing targeted cancer therapies.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.6K
Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

11.1K

Related Experiment Videos

Last Updated: Mar 11, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.6K
Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

11.1K

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Structural Biology
  • Drug Discovery

Background:

  • The cell cycle's precise progression depends on sequential activation of cyclin-dependent kinases (CDKs) by specific cyclins.
  • Previous work suggested that CDK-cyclin complex conformations and activation speeds are tailored to distinct cell cycle phases.
  • The mechanisms ensuring ordered progression through S and M phases by similar CDK complexes, like Cyclin-A/CDK2 and Cyclin-A/CDK1, remain unclear.

Purpose of the Study:

  • To investigate if the principle of phase-specific conformational tuning applies to later cell cycle phases (S and M).
  • To elucidate how structurally similar CDK complexes (Cyclin-E/CDK2, Cyclin-A/CDK2, Cyclin-A/CDK1) perform distinct functions.
  • To explore strategies for targeted therapeutic intervention, specifically developing an allosteric degrader for Cyclin-E.

Main Methods:

  • Molecular dynamics simulations to analyze the dynamic behavior and conformational energy landscapes of CDK-cyclin complexes.
  • Kinetic profiling to assess the catalytic efficiency and functional differences between complexes.
  • Computational modeling to design and validate an allosteric degrader targeting a specific Cyclin-E/CDK2-cereblon conformational state.

Main Results:

  • Functional differences among Cyclin-E/CDK2, Cyclin-A/CDK2, and Cyclin-A/CDK1 correlate with distinct conformational energy landscapes and kinetic profiles.
  • The Cyclin-E/CDK2 complex exhibits a stable interface, suggesting conformational constraint and reduced dependence on catalytic output for G1/S transition.
  • Cyclin-A/CDK2 demonstrates high catalytic efficiency, potentially preventing DNA rereplication by preorganizing the CDK2 DFG-motif for S-phase factor phosphorylation.

Conclusions:

  • The conformational dynamics and kinetic profiles of CDK-cyclin complexes are critical for their distinct roles in cell cycle progression.
  • The study proposes a novel allosteric degrader strategy for selective Cyclin-E degradation, validated by modeling a known CDK2 degrader.
  • This work establishes structural parameters for targeting specific conformational states of CDK complexes, paving the way for precision therapeutics.